Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy

NCT02135510

Conditions
Solid Tumors
Locations
  • Medisch Centrum Alkmaar Alkmaar, North Holland, Netherlands
  • Ziekenhuis Amstelland Amstelveen, North Holland, Netherlands
  • Gemini Ziekenhuis Den Helder, North Holland, Netherlands
  • Tergooiziekenhuizen Hilversum, North Holland, Netherlands
View Trial Details
Completed

A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors

NCT02650713

Conditions
Solid Tumors
Locations
  • UCLA Cancer Center Santa Monica, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Smilow Cancer Hospital at Yale- New Haven Oncology Investigational Drug Pharmacy New Haven, Connecticut, United States
View all 24 locations
View Trial Details
Completed

A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors

NCT02350673

Conditions
Solid Tumors
Locations
  • Yale Cancer Center; Medical Oncology New Haven, Connecticut, United States
  • Columbia Univ Med Ctr New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • SCRI-Tennessee Oncology Nashville, Tennessee, United States
View all 14 locations
View Trial Details
Completed

Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors

NCT01988896

Conditions
Solid Tumors
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Rocky Mountain Cancer Center - Denver Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Massachusets General Hospital Clinical Trial Network and Institute Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

NCT02304393

Conditions
Solid Tumors
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University Health Network; Princess Margaret Hospital; Medical Oncology Dept Toronto, Ontario, Canada
  • Jewish General Hospital / McGill University Montreal, Quebec, Canada
  • Rigshospitalet; Onkologisk Klinik København Ø, Denmark
View Trial Details
Completed

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

NCT01770353

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • HonorHealth Scottsdale, Arizona, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions